These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26592724)

  • 1. Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.
    Riviere JE; Gabrielsson J; Fink M; Mochel J
    J Vet Pharmacol Ther; 2016 Jun; 39(3):213-23. PubMed ID: 26592724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.
    Lin Z; Gehring R; Mochel JP; Lavé T; Riviere JE
    J Vet Pharmacol Ther; 2016 Oct; 39(5):421-38. PubMed ID: 27086878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling.
    Li M; Gehring R; Lin Z; Riviere J
    J Pharm Sci; 2015 Apr; 104(4):1230-9. PubMed ID: 25641543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics.
    Bon C; Toutain PL; Concordet D; Gehring R; Martin-Jimenez T; Smith J; Pelligand L; Martinez M; Whittem T; Riviere JE; Mochel JP
    J Vet Pharmacol Ther; 2018 Apr; 41(2):171-183. PubMed ID: 29226975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SAS/IML program for simulating pharmacokinetic data.
    Russek-Cohen E; Martinez MN; Nevius AB
    Comput Methods Programs Biomed; 2005 Apr; 78(1):39-60. PubMed ID: 15780889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population variability in animal health: Influence on dose-exposure-response relationships: Part II: Modelling and simulation.
    Martinez MN; Gehring R; Mochel JP; Pade D; Pelligand L
    J Vet Pharmacol Ther; 2018 Aug; 41(4):E68-E76. PubMed ID: 29806231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative simulation for reasoning about physiological models of drug kinetics and effects.
    Leemann TD; Blaschke TF
    Schweiz Med Wochenschr; 1990 Dec; 120(49):1849-52. PubMed ID: 2263925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues.
    Martín-Jiménez T; Riviere JE
    J Vet Pharmacol Ther; 1998 Jun; 21(3):167-89. PubMed ID: 9673958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.
    Toutain PL
    AAPS PharmSci; 2002; 4(4):E38. PubMed ID: 12646010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
    Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
    Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study design and simulation approach.
    Läer S; Meibohm B
    Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in veterinary clinical and fundamental pharmacology: past and future in The Netherlands.
    van Miert AS
    Vet Q; 2000 Jan; 22(1):3-11. PubMed ID: 10682380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.
    Lin Z; Li M; Gehring R; Riviere JE
    J Pharm Sci; 2015 Jan; 104(1):233-43. PubMed ID: 25407474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based drug development: the road to quantitative pharmacology.
    Zhang L; Sinha V; Forgue ST; Callies S; Ni L; Peck R; Allerheiligen SR
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):369-93. PubMed ID: 16770528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mathematical methods in pharmacokinetic modeling.
    Durisová M; Dedík L
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):335-42. PubMed ID: 15853925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of modeling and simulation in pediatric investigation plans.
    Manolis E; Osman TE; Herold R; Koenig F; Tomasi P; Vamvakas S; Saint Raymond A
    Paediatr Anaesth; 2011 Mar; 21(3):214-21. PubMed ID: 21244569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating Pharmacokinetic and Pharmacodynamic Data into Practice.
    Visser M
    Vet Clin North Am Exot Anim Pract; 2018 May; 21(2):169-182. PubMed ID: 29655465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of physiologically based pharmacokinetic modeling and simulation in drug development.
    Shardlow CE; Generaux GT; Patel AH; Tai G; Tran T; Bloomer JC
    Drug Metab Dispos; 2013 Dec; 41(12):1994-2003. PubMed ID: 24009310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.